BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27494892)

  • 1. Sirtuin 1 stimulates the proliferation and the expression of glycolysis genes in pancreatic neoplastic lesions.
    Pinho AV; Mawson A; Gill A; Arshi M; Warmerdam M; Giry-Laterriere M; Eling N; Lie T; Kuster E; Camargo S; Biankin AV; Wu J; Rooman I
    Oncotarget; 2016 Nov; 7(46):74768-74778. PubMed ID: 27494892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.
    He P; Yang JW; Yang VW; Bialkowska AB
    Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer.
    Wauters E; Sanchez-Arévalo Lobo VJ; Pinho AV; Mawson A; Herranz D; Wu J; Cowley MJ; Colvin EK; Njicop EN; Sutherland RL; Liu T; Serrano M; Bouwens L; Real FX; Biankin AV; Rooman I
    Cancer Res; 2013 Apr; 73(7):2357-67. PubMed ID: 23370328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
    Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
    Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
    Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
    J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma.
    Stenzinger A; Endris V; Klauschen F; Sinn B; Lorenz K; Warth A; Goeppert B; Ehemann V; Muckenhuber A; Kamphues C; Bahra M; Neuhaus P; Weichert W
    BMC Cancer; 2013 Oct; 13():450. PubMed ID: 24088390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D
    DelGiorno KE; Chung CY; Vavinskaya V; Maurer HC; Novak SW; Lytle NK; Ma Z; Giraddi RR; Wang D; Fang L; Naeem RF; Andrade LR; Ali WH; Tseng H; Tsui C; Gubbala VB; Ridinger-Saison M; Ohmoto M; Erikson GA; O'Connor C; Shokhirev MN; Hah N; Urade Y; Matsumoto I; Kaech SM; Singh PK; Manor U; Olive KP; Wahl GM
    Gastroenterology; 2020 Nov; 159(5):1866-1881.e8. PubMed ID: 32717220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer.
    Zhao G; Qin Q; Zhang J; Liu Y; Deng S; Liu L; Wang B; Tian K; Wang C
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S301-11. PubMed ID: 22552606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.
    Lee AYL; Dubois CL; Sarai K; Zarei S; Schaeffer DF; Sander M; Kopp JL
    Gut; 2019 Mar; 68(3):487-498. PubMed ID: 29363536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early requirement of Rac1 in a mouse model of pancreatic cancer.
    Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
    Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor 2 mRNA binding protein 2 promotes aerobic glycolysis and cell proliferation in pancreatic ductal adenocarcinoma via stabilizing GLUT1 mRNA.
    Huang S; Wu Z; Cheng Y; Wei W; Hao L
    Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):743-752. PubMed ID: 31089713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.
    Yamaguchi J; Mino-Kenudson M; Liss AS; Chowdhury S; Wang TC; Fernández-Del Castillo C; Lillemoe KD; Warshaw AL; Thayer SP
    Gastroenterology; 2016 Dec; 151(6):1232-1244.e10. PubMed ID: 27523981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes.
    Li A; Morton JP; Ma Y; Karim SA; Zhou Y; Faller WJ; Woodham EF; Morris HT; Stevenson RP; Juin A; Jamieson NB; MacKay CJ; Carter CR; Leung HY; Yamashiro S; Blyth K; Sansom OJ; Machesky LM
    Gastroenterology; 2014 May; 146(5):1386-96.e1-17. PubMed ID: 24462734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA2 dysfunction promotes malignant transformation of pancreatic intraepithelial neoplasia.
    Wang Q; Liu H; Liu T; Shu S; Jiang H; Cheng S; Yuan Y; Yang W; Wang L
    Anticancer Agents Med Chem; 2013 Feb; 13(2):261-9. PubMed ID: 22934697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
    Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J
    Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma.
    Li JT; Yin M; Wang D; Wang J; Lei MZ; Zhang Y; Liu Y; Zhang L; Zou SW; Hu LP; Zhang ZG; Wang YP; Wen WY; Lu HJ; Chen ZJ; Su D; Lei QY
    Nat Cell Biol; 2020 Feb; 22(2):167-174. PubMed ID: 32029896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BRG1/SOX9 axis is critical for acinar cell-derived pancreatic tumorigenesis.
    Tsuda M; Fukuda A; Roy N; Hiramatsu Y; Leonhardt L; Kakiuchi N; Hoyer K; Ogawa S; Goto N; Ikuta K; Kimura Y; Matsumoto Y; Takada Y; Yoshioka T; Maruno T; Yamaga Y; Kim GE; Akiyama H; Ogawa S; Wright CV; Saur D; Takaori K; Uemoto S; Hebrok M; Chiba T; Seno H
    J Clin Invest; 2018 Aug; 128(8):3475-3489. PubMed ID: 30010625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT1 promotes GLUT1 expression and bladder cancer progression via regulation of glucose uptake.
    Chen J; Cao L; Li Z; Li Y
    Hum Cell; 2019 Apr; 32(2):193-201. PubMed ID: 30868406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.